Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial - Concepedia

Concepedia

Publication | Closed Access

Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial

102

Citations

37

References

2008

Year

Oleg Gluz, Ulrike Nitz, Nadia Harbeck, Evelyn Ting, Ronald Kates, Alexander Herr, Walter Lindemann, Christian Jackisch, Wolfgang E. Berdel, Hartmut Kirchner,

Annals of Oncology

Breast OncologyOncologyAdjuvant ChemotherapyBreast CancerWsg Am-01 TrialCancer TreatmentDose IntensificationMedicineRadiation Oncology

References

	Year	Citations

Page 1

Page 1